Key result
Two human induced pluripotent stem cell lines were generated from CPVT patients carrying RYR2 mutations, demonstrating pluripotency, differentiation capability, and karyotype stability.
Why the study?
CPVT is a congenital arrhythmic syndrome caused by RYR2 mutations that lead to lethal arrhythmias and sudden cardiac death, requiring reliable tools to investigate the phenotype and underlying mechanisms.
The generated patient-specific iPSC lines provide a reliable tool to investigate the CPVT phenotype and understand underlying mechanisms.
May support mechanistic CPVT studies; leaves open clinical translation pending validation.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a congenital arrhythmic syndrome caused by the RYR2 gene encoded ryanodine receptor. Mutations on RYR2 are commonly associated with ventricular tachycardia after adrenergic stimulation, leading to lethal arrhythmias and sudden cardiac death. We generated two human induced pluripotent stem cell (iPSC) lines from CPVT affected patients carrying single missense heterozygote RYR2 mutations, c.1082 G > A and c.100 A > C. Pluripotency and differentiation capability into derivatives of three germ layers were evaluated along with karyotype stability in the report. The generated patient-specific iPSC lines provide a reliable tool to investigate the CPVT phenotype and understand underlaying mechanisms.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2023) studied Catecholaminergic polymorphic ventricular tachycardia (CPVT) (n=2). Generation of induced pluripotent stem cell (iPSC) lines was evaluated on Pluripotency, differentiation capability, and karyotype stability. Two human induced pluripotent stem cell lines were generated from CPVT patients carrying RYR2 mutations, demonstrating pluripotency, differentiation capability, and karyotype stability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: